Xtandi (enzalutamide) - Pfizer, Astellas
Ac-225 rosopatamab tetraxetan (CONV01-α) - Dominari Holdings
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT04946370
 
Sep 26, 2025
 
Next